All cancers have mutations, and this is exactly what the immunotherapy is attacking. Ironically, the unique mutations that cause cancer are probably the best targets for treating cancer." ACT therapy used by researchers is different from chimeric antigen receptor T cell (CAR-T) therapy, the most promising immunotherapy for cancer treatment, which has shown remarkable ability to eliminate various kinds of tumors, especially for B cell malignancies, with up to 95% response rates and durable
...
Más informaciones
